DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

H.C. Wainwright Reiterates Buy on Avid Bioservices, Lowers Price Target to $9

H.C. Wainwright analyst Joseph Pantginis reiterates Avid Bioservices (NASDAQ:CDMO) with a Buy and lowers the price target from $11 to $9.

Benzinga · 03/11/2020 12:04

H.C. Wainwright analyst Joseph Pantginis reiterates Avid Bioservices (NASDAQ:CDMO) with a Buy and lowers the price target from $11 to $9.